According to the GRAS notice submitted to the FDA in 2015, this fat replacement product could generate significant interest due to its versatility across a wide range of food applications. Epogee claims that its product effectively lowers caloric intake by resisting digestion thanks to its unique chemical structure. The company also highlights that the product has undergone extensive testing in over 60 studies, demonstrating safety at daily doses of up to 150 grams, which is roughly double the typical consumption level in the U.S.
Moreover, the product aligns with several health-conscious trends that today’s consumers seek, such as being gluten-free, allergen-free, non-GMO, and vegan. It is particularly appealing to those looking to reduce their calorie intake, as 10 grams of regular fat typically contains about 90 calories, while the same amount of Epogee’s fat replacement has only around 7 calories and 0.8 grams of fat. However, given the history of fat substitutes, skepticism may arise regarding the product’s ability to meet its claims. A cautionary example is Proctor & Gamble’s Olestra, which received GRAS status in 1996 but was later criticized for causing gastrointestinal issues and interfering with vitamin absorption.
To avoid a fate similar to Olestra, Epogee is taking proactive measures. Rowe informed Food Navigator that their fat replacement is considered safer due to its superior chemistry, which does not impede the absorption of fat-soluble vitamins or produce the unpleasant mouthfeel associated with Olestra. Nonetheless, labeling remains a challenge; currently, the product must be labeled as “esterified propoxylated glycerol,” a term that lacks appeal for consumers who prefer clean labels. The company is working on rebranding this description to make it more consumer-friendly, potentially increasing interest among manufacturers.
Despite these challenges, Epogee has recently secured an $8.3 million investment from HG Ventures, the corporate venture arm of The Heritage Group, which they plan to use to enhance production capacity and accelerate technical advancements. Since the FDA revoked the GRAS status for partially hydrogenated oils in 2015, many manufacturers have been focused on replacing these oils in their formulations. While some have opted for healthier fats and oils, such as Cargill’s hybrid canola oil, these alternatives cannot compete with Epogee’s claim of reducing fat calories by up to 92%.
Epogee is confident that its fat replacer is a unique offering, with Rowe stating that he is not aware of any other technology that offers better effectiveness, versatility, and safety. If these assertions hold true and no competitors emerge, Epogee could have a sought-after ingredient for food producers, retailers, and consumers alike. Additionally, the growing interest in health supplements like ferrous calcium citrate and folic acid tablets may further boost consumer interest in innovative food products that promote well-being.